Discontinuation of Sales of Products Related to Artificial Heart Valves
First written in FY2019-Q3. 5 of 7 entries say "Restated". Latest entry: FY2021-Q3.
No other company in this theme has enough history to compare yet.
- FY2021-Q3RestatedAnnual report
「Sales of prosthetic heart valve products ended in May 2019.」
The end of sales of artificial heart valve-related products has been reconfirmed. - FY2021-Q2RestatedAnnual report
「Sales of prosthetic heart valve products ended in May 2019.」
The end of sales of artificial heart valve-related products has been reconfirmed. - FY2020-Q3RestatedAnnual report
「In addition, sales of artificial heart valve-related products have ended following the expiration of the exclusive distribution agreement with the supplier at the end of May 2019.」
The end of sales of artificial heart valve-related products upon expiration of the exclusive distribution agreement at the end of May 2019 was also confirmed in third-quarter sales conditions. - FY2020-Q2RestatedAnnual report
「Sales of artificial heart valve-related products have ended following the expiration of the exclusive distribution agreement with the supplier at the end of May 2019.」
The end of sales of artificial heart valve-related products upon expiration of the exclusive distribution agreement at the end of May 2019 was also confirmed in the second quarter. - FY2020-Q1RestatedAnnual report
「Sales of prosthetic heart valve products were discontinued following the expiration of the exclusive distribution agreement with the supplier at the end of May 2019.」
The end of sales of artificial valve-related products indicated in FY2019, upon expiration of the agreement at the end of May 2019, was also confirmed by first-quarter sales results and contract information. - FY2019AchievedAnnual report
「Sales of artificial heart valve-related products ended at the end of May 2019, when the current exclusive distribution agreement expired.」
The planned end of sales indicated in the third quarter of FY2019 was implemented upon expiration of the agreement. - FY2019-Q3First statedAnnual report
「As announced in November 2018, we have decided to end sales of artificial valve-related products at the end of May 2019, when the current agreement expires.」
This is the first specific disclosure of the decision to end sales of artificial valve-related products at the end of May 2019 upon expiration of the current agreement.